what are you looking for?
Search
English

English

Ferritin Quantitative Test
Home

Fluorescent Immunoassay

Cardiac Marker

3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test
Biotime 3 in 1 (cTnI/CK-MB/Myo) rapid fluorescence immunoassay test Biotime 3 in 1 (cTnI/CK-MB/Myo) rapid fluorescence immunoassay test

3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test

3 in 1 test kit has a very high specificity and sensitivity for the detection of AMI, making a correct and timely diagnosis for patients with chest pain or clinically suspected AMI, and thus providing validly basis for clinicians with prompt rescue and treatment.
Inquiry now Download
Product Detail
Product Introduction
The creatine troponin complex, formed by cardiac muscle creatine troponin I (cTnI), troponin T (TnT), and troponin C (TnC), can adjust the interaction between actin and myosin. The concentration of cTnI is rare low in healthy human blood; However, when acute myocardium infarction occurs, the cTnI is released into the blood quickly and the concentration of cTnI increases from the fourth hour to the sixth hours, which can maintain 6 days to 10 days. Therefore, cTnI is regarded as a marker for myocardial infarction. 
Creatine Kinase(CK) is a dimer existing as three isoenzymes. CK mainly exists in skeletal muscle, cardiac muscle, and brain tissue. There are three types of isoenzymes, including BB (brain type), MM (skeleton-type), and MB(hybridization type). The level of CK- MB in the blood is abnormal after the fourth hour to the sixth hour with the symptom of acute myocardial infarction; furthermore, it reaches its peak at the 18th-24th hour and recovers to its normal level after the second or the third day. Thus CK-MB is regarded as a marker for acute myocardial infarction. 
Myo is a plasmon of low molecular weight, whose speed released is faster than another label of the heart muscle when the heart is hurt. Its concentration exceeds the normal level after 1 hour and reaches a peak after the fourth or the eighth hour when faced with myocardial infarction. Therefore, Myo is regarded as a marker for early acute myocardial infarction. 



Product Specification

Specimen Types
 WB/Plasma
Specimen Capacity
 WB:80μL; Plasma:50μL
Reaction Time
 15 min
Sample Capacity
 80μL
Clinical Significance
 cTnI>0.3ng/mL; 
Myo>55ng/mL; 
CK-MB>5ng/mL High risk of MI



Advantages

√ Equipped with special dropper consumables, the operation is easier and more suitable for clinical use
√ Low sample requirements: whole blood can be processed without centrifugation
√ 3 in 1 (cTnI/CK-MB/Myo) detections improve the sensitivity and accuracy of results and reduce misdiagnosis caused by window reasons



Clinical significance
√ 3 in 1 (cTnI/CK-MB/Myo) detection has high sensitivity, better specificity, and more accurate results
√ Assess the area of myocardial infarction, detect reperfusion and recurrence of myocardial infarction, etc.
√ As an important indicator of brain injury, nervous system disease, carbon monoxide poisoning diagnosis, and treatment effect evaluation



Application
ICU, Respiratory Medicine, Emergency Department, Cardiology, Laboratory, Emergency Car

Related Tags : cardiac combo test cardiac biomarker test AMI test
Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Categories
New Products
Related Products
Biotime cTnI rapid quantitative test
cTnI Rapid Quantitative Test
cTnI is a myocardial marker with high specificity and good sensitivity. The Biotime cTnI test kit has a wide detection range and high accuracy.
Biotime 5 in 1 cTnI CK-MB Myo NTproBNP D Dimer rapid fluorescence immunoassay test
5 in 1 (cTnI/ CK-MB/ Myo/ NT-proBNP/ D-Dimer) Rapid Quantitative Test
Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain, suspected Acute Coronary Syndrome(ACS) and Heart Failure(HF), etc.
Biotime hFABP Rapid Quantitative Test
hFABP Rapid Quantitative Test
Biotime hFABP test kit is a fluorescent immunoassay for the detection of hFABP antigen in human serum and plasma samples.
Biotime Myo Rapid Quantitative Test
Myo Rapid Quantitative Test
Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.
Biotime CKMB Rapid Quantitative Test
CK-MB Rapid Quantitative Test
CK-MB is very valuable for the early diagnosis of AMI. The Biotime CK-MB test kit can perform the test accurately and rapidly within 15 minutes with Biotime Analyzers.
Biotime D Dimer Chronic heart failure
D-Dimer Rapid Quantitative Test
Biotime D-Dimer test kit (Analyzer + Test cassette) is performed to help rule out Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and stroke. It can perform the test accurately and rapidly within 3 min with the Biotime immunofluorescence analyzer.
Biotime NT-proBNP Rapid Quantitative Test
NT-proBNP Rapid Quantitative Test
NT-proBNP is a marker for detecting heart function, with a long half-life and high specificity. Biotime NT-proBNP test kit detects the amount of NT-proBNP in human whole blood, serum and plasma samples.
Biotime BNP Rapid Quantitative Test
BNP Rapid Quantitative Test
During heart failure, the heart makes two proteins, called B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NT-proBNP). Levels of both in the blood go up when heart failure gets worse and go down when it gets better.
  • Facebook
  • Twitter
  • Linkedin
  • YouTube
  • Instagram
Quick Link
Hot Tags
products

Copyright © 2013-2024 Xiamen Biotime Biotechnology Co., Ltd.. All Rights Reserved.

IPv6 network supported

Power by
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact